Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial)

BACKGROUND: At present, women with threatened preterm labor before 32 weeks of gestation are, after transfer to a perinatal center, treated with tocolytics and corticosteroids. Many of these women are treated unnecessarily. Fibronectin is an accurate predictor for the occurrence of preterm birth amo...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Vis, Jolande Y, Wilms, Femke F, Oudijk, Martijn A, Porath, Martina M, Scheepers, Hubertina CJ, Bloemenkamp, Kitty WM, Bolte, Annemiek C, Cornette, Jérôme, Derks, Jan B, Duvekot, Johannes J, van Eyck, Jim, Kwee, Anneke, Opmeer, Brent C, van Pampus, Maria G, Lotgering, Fred K, Scherjon, Sicco A, Sollie, Krystyna M, Spaanderman, Marc EA, Willekes, Christine, van der Post, Joris AM, Mol, Ben Willem J
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2009
Teme:
Study Protocol
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2752451/
https://ncbi.nlm.nih.gov/pubmed/19723320
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2393-9-38
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items